Mucopolysaccharidosis type II (MPS II): Evaluate of food intakes in patients on enzyme replacement therapy

被引:0
|
作者
Oliveira, R. B. [1 ]
Frangipani, B. J. [1 ]
Lauandos, J. R. [1 ]
Micheletti, C. [1 ]
Silveira, M. T. [1 ]
Vertemati, T. [1 ]
Martins, A. M. [1 ]
机构
[1] CREIM UNIFESP, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
397P
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [21] Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
    da Silva, Edina M. K.
    Louzada Strufaldi, Maria Wany
    Andriolo, Regis B.
    Silva, Laercio A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (11):
  • [22] A SYSTEMATIC LITERATURE REVIEW: ENZYME REPLACEMENT THERAPY IN MUCOPOLYSACCHARIDOSIS TYPE II
    Alegra, T.
    Eizerik, D.
    Cerqueira, C. C. S.
    Pereira, T., V
    Schwartz, I. V. D.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S230 - S230
  • [23] Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
    da Silva, Edina M. K.
    Strufaldi, Maria Wany Louzada
    Andriolo, Regis B.
    Silva, Laercio A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (01):
  • [24] Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)
    da Silva, Edina M. K.
    Louzada Strufaldi, Maria Wany
    Andriolo, Regis B.
    Silva, Laercio A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [25] Resolution of Hydronephrosis in a Patient With Mucopolysaccharidosis Type II With Enzyme Replacement Therapy
    Nishiyama, Kei
    Imai, Takashi
    Ohkubo, Kazuhiro
    Sanefuji, Masafumi
    Takada, Hidetoshi
    UROLOGY, 2017, 101 : 163 - 165
  • [26] MUCOPOLYSACCHARIDOSIS: EFFECTS OF ENZYME-REPLACEMENT THERAPY IN 27 CHILDREN WITH MPS I, II AND VI
    Hasanoglu, A.
    Tumer, L.
    Ezgu, F. S.
    Okur, I
    Eminoglu, F. T.
    Kasapkara, C. S.
    Kucukcongar, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 : S147 - S147
  • [27] Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy
    Carlos Eduardo Diaz Jacques
    Gilian Guerreiro
    Franciele Fatima Lopes
    Carolina F. Moura de Souza
    Roberto Giugliani
    Carmen Regla Vargas
    Cell Biochemistry and Biophysics, 2023, 81 : 533 - 542
  • [28] Clinical and polysomnographic evaluation of two patients with mucopolysaccharidosis Type II receiving enzyme replacement therapy
    Boy, R.
    Paiva, I. S.
    Maciel, R.
    Lemos, C. C. M. G.
    Ferreira, P. D. M.
    Stajnbok, D.
    Guardin, L.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 : S54 - S54
  • [29] Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy
    Jacques, Carlos Eduardo Diaz
    Guerreiro, Gilian
    Lopes, Franciele Fatima
    de Souza, Carolina F. Moura
    Giugliani, Roberto
    Vargas, Carmen Regla
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2023, 81 (3) : 533 - 542
  • [30] EFFECTS OF ENZYME REPLACEMENT THERAPY (ERT) ON JOINT MOBILITY IN 27 PATIENTS(PTS) WITH MUCOPOLYSACCHARIDOSIS (MPS) I, II AND VI
    Furlan, F.
    Rigoldi, M.
    Santus, F.
    Tedesco, L.
    Parini, R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S207 - S207